BioCentury
ARTICLE | Financial News

Funding roundup: Esperion, Retrophin, Assembly, Concert

March 20, 2015 2:03 AM UTC

Esperion Therapeutics Inc. (NASDAQ:ESPR), Retrophin Inc. (NASDAQ:RTRX), Assembly Biosciences Inc. (NASDAQ:ASMB) and Concert Pharmaceuticals Inc. (NASDAQ:CNCE) raised $430 million in follow-on offerings since market close Wednesday.

Esperion raised $175 million through the sale of 1.8 million shares at $100. Credit Suisse; RBC Capital Markets; UBS; JMP Securities; Stifel; and Needham were underwriters. Esperion proposed to raise $150 million late Tuesday after its shares closed at an all-time high of $99.60 on news of positive Phase IIb data for ETC-1002 to treat hypercholesterolemia. The stock gained $4.42 to $110.14 on Thursday (see BioCentury Extra, March 17). ...